National Hepatitis Elimination Profiles
On World Hepatitis Day, the Coalition for Global Hepatitis Elimination announced the launch of an initiative to develop National Hepatitis Elimination Profiles for 30 high-burden countries. Developed in collaboration with local stakeholders, the profiles comprehensively assess the status of hepatitis elimination and will be a critical resource for country and global program planning, advocacy, and resource mobilization efforts.
In 2020, The Coalition for Global Hepatitis Elimination developed data dashboards for over 190 countries. The dashboard provide data available globally to monitor vaccination coverage, access to affordable therapies and progress towards hepatitis elimination goals. Working with local partners, the National Hepatitis Elimination Profiles build on the dashboards by collecting additional data available locally and translating the data into advocacy tools for policy development, resource mobilization, and greater commitments to the 2030 goals for hepatitis elimination.
1. Bring together key data to assess status of hepatitis elimination efforts:
- Hepatitis burden
- Implementation of hepatitis prevention, testing and treatment services
- Policy development
- Health equity for key populations
2. Assess progress toward program targets and health outcome goals
3. Highlight achievements, challenges, and feasible next steps
The profiles are also meant to be dynamic and will continue to be updated as new information is shared.
Find out more:
Funding for this N-HEP was provided by Gilead Sciences. The Coalition for Global Hepatitis Elimination retained final control over the content.
To kick-off the initiative, the Coalition released profiles for six countries, including Argentina, Brazil, Canada, Mexico, Peru, and the United States. In total, profiles for 30 countries will be developed. To be alerted when new new National Hepatitis Elimination Profiles are posted, sign-up for the Coalition newsletter here or email the Coalition at globalhep [at] taskforce.org,
This profile was developed with input from CAITE, the Canadian Association for the Study of the Liver, and Action Hepatitis Canada.
This profile was developed with input from American Association for the Study of the Liver (AASLD), the Hepatitis B Foundation, the National Association of State and Territorial AIDS Directors (NASTAD), the National Viral Hepatitis Roundtable (NVHR), and US CDC.